B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Pd 169316

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pd 169316, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sb
2 shared targets
gw559768x
2 shared targets
vactosertib
2 shared targets
galunisertib
2 shared targets
encorafenib
2 shared targets
lenvatinib
2 shared targets
regorafenib
2 shared targets
bafetinib
2 shared targets
cep
2 shared targets
golvatinib
2 shared targets
Loading evidence profile...

This evidence profile for Pd 169316 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.